Chinese Co. To Pay $2.2M To End Vitamin C Antitrust Case

Law360, New York (December 16, 2013, 7:31 PM EST) -- Weisheng Pharmaceutical Co. Ltd. and parent company CSPC Pharmaceutical Group Ltd., formerly known as China Pharmaceutical Group Ltd., have agreed to pay $2.2 million to settle with consumers and other indirect purchasers over claims that they conspired to fix vitamin C prices, the plaintiffs said Friday.

The indirect purchaser plaintiffs moved for preliminary approval of the deal, which leaves only Hebei Welcome Pharmaceutical Co. Ltd. fighting the antitrust case.

"Settlement talks with Weisheng and CSPC ... began in summer of 2013, and underwent several rounds of...
To view the full article, register now.